June 12, 2018 Liz Borkowski, MPH

A proposed EPA rule that would sharply restrict the studies the agency can use when regulating faces pushback from the agency’s Science Advisory Board and a bipartisan group of more than 100 Congress members. The agency has extended the comment period and scheduled a hearing, but still seems determined to move ahead with a deeply flawed rule.